Bio-equivalency tested drug promptly to review its NHI price.
Published: 2002-09-26 06:58:00
Updated: 2002-09-26 06:58:00
The MOHW instructed to the Health Insurance Review Agency (HIRA) recently that the national health insurance (NHI) price authorization should be made far quickly for the drug of which its bio-equivalency test was completed and passed,
In the past the price review for such bio-equivalent test...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
